1. Introduction {#sec1}
===============

As part of its life cycle, the malaria parasite invades erythrocytes and this intraerythrocytic stage is responsible for the disease. During its intraerythrocytic stage, the parasite extensively modifies the host erythrocyte ([@bib7]). These modifications include the formation of multiple membranous compartments within the erythrocyte cytoplasm, such as exomembranes systems, the parasitophorous vacuole, the tubovesicular network ([@bib22]), Maurer\'s' clefts, the caveole-vesicle complex, J dots and other mobile compartments. Changes in the host erythrocyte cell membrane are primarily in its rigidity, adhesiveness, and permeability to nutrients. These changes promote the survival of the parasite and are often virulence factors. For example, the adhesiveness of *Plasmodium falciparum*-infected erythrocytes promotes survival of the parasite by sequestering infected erythrocytes to the capillary endothelium in the deep vasculature and thereby preventing clearance in the spleen ([@bib8]). Cytoadherence and sequestration are responsible for increased severity associated with *P. falciparum* infections ([@bib2]). This cytoadherence is mediated by a parasite protein (*Pf*EMP1) that is expressed on the surface of the infected erythrocyte and serves as a ligand to bind to receptors on endothelial cells ([@bib21]). The modifications of the host erythrocyte are mediated by the export of parasite proteins into the host erythrocyte and the specific targeting of these exported proteins to distinct locations in the infected cell. In fact, the number of proteins exported into the host erythrocyte may account for 8--10% of the parasite\'s genome ([@bib19]). In regards to how the parasite exports proteins into the host erythrocyte, a *Plasmodium* export compartment (PEC), that is an early step in the targeting of proteins to the host erythrocyte, has been proposed ([@bib30]). This compartment is present throughout the erythrocytic stage of the parasite and is involved in the export of several different proteins that are targeted to extraparasite locations such as the parasitophorous vacuole, inclusions within the infected erythrocyte, or the host erythrocyte membrane. It is not clear if the PEC is a distinct compartment from the ER or if the PEC is a domain of the ER that specializes in the export of proteins into the host erythrocyte. Consistent with the PEC being a domain of the ER ([@bib17]) have recently suggested that proteins with the host targeting sequence called PEXEL are sorted to a distinct location on the ER membrane. This implies that the *Plasmodium* ER of the blood stage parasite has distinct domains. Once passing through the PEC, exported proteins are then moved into the parasitophorous vacuole and translocated into the host erythrocyte and then directed to their final locations by various mechanisms ([@bib7]).

The exact nature of PEC is unknown and possible resident proteins include a SERCA-like ATPase unique to the Apicomplexa and COPII components ([@bib30]). In addition, several monoclonal antibodies that may recognize proteins of the PEC have been previously described ([@bib3]). These antibodies were generated by immunizing mice with a purified and concentrated membrane fraction released during the *in vitro* culture of *P. falciparum* ([@bib28]). The previously described monoclonal antibodies include Mab4F8, which recognizes a protein of 45 kDa, Mab134 that recognizes a protein doublet of 44/22 kDa, and Mab7 and MabIG2 that both recognize a protein of 68 kDa. These proteins are conserved in *Plasmodium* species in that the antibodies also recognize homologues in rodent *Plasmodium* species. However, the identities of these potential PEC resident proteins are currently unknown.

As a continuation of this previous study we determined the identity of the 68 kDa protein recognized by Mab7 (*Pf*68 kDa) following affinity purification and peptide fingerprinting using mass spectrometry. The results conclusively show that *Pf*68 kDa is equivalent to the *P. falciparum* homolog of the ER-resident HSP70, or *Pf*HSP70-2.

2. Methods {#sec2}
==========

2.1. Culture of *P. falciparum* {#sec2.1}
-------------------------------

*P. falciparum*-infected erythrocytes from the FCB-1 strain was maintained in continuous culture as previously described ([@bib26]). Parasites were synchronized using 5% sorbitol to eliminate mature forms according to ([@bib15]). The culture was maintained until reaching a 5--15% parasitemia. After the rings matured, trophozoite and schizont-infected erythrocytes were concentrated by gelatin flotation ([@bib9]).

2.2. Preparation of *affinity* column {#sec2.2}
-------------------------------------

Ascitic fluid containing Mab7 was produced in Balb/c mice (10--12 weeks old) following immunosuppression with Pristan® (Sigma) and purified by ion exchange chromatography using monoQ sepharose (BioRad). The pooled fractions were concentrated with an Amicon filter with a \<30 kDa cutoff and then dialyzed with a 0.1 M carbonate buffer, pH 8.6. Total protein concentration was determined by the bicinchoninic acid method ([@bib27]) Cyanogen bromide activated resin was obtained from Pierce (Rockford IL, USA) and prepared according to their recommendations. Mab7 was conjugated to the resin and washed with phosphate-buffered saline (PBS) 10mM sodium phosphate, 0.145 M NaCl, pH 7.4, blocked with 0.1 M glycine, pH8.0, and washed again with PBS pH 7.4.

2.3. Protein purification and MS/MS analysis {#sec2.3}
--------------------------------------------

Total protein extracts were prepared from enriched and intact *P. falciparum*-infected erythrocytes prepared by sorbitol synchronization and gelatin flotation as described above. Infected erythrocytes were hemolyzed with 20 volumes of hypotonic 5mM sodium phosphate, pH 8.0, containing protease inhibitors ([@bib18]). The lysate was centrifuged at 10,000Xg for 20 min. The pellet fractions were suspended in 10 volumes of 1% Triton X-100 in PBS plus protease inhibitors and were incubated for 30 min at 4 °C. The extracts were centrifuged at 45,000 x g for 1 h. The supernatant containing the Triton X-100 solubilized proteins was subjected to affinity chromatography.

The Triton X-100 extract was passed over the Mab7 affinity column and then washed with PBS containing 0.1% Triton X-100 to remove non-specific proteins. The purified protein was eluted with 0.1 M glycine, pH 2.7, containing 0.1% Triton X-100. The eluted protein was precipitated with 10% trichloroacetic acid and preserved at -20 °C. This affinity purified 68 kDa protein was analyzed by SDS-PAGE and immunoblotting using Mab7 as previously described ([@bib3]).

The band corresponding to the 68 kDa protein was excised and shipped to the Proteome Factory AG (<https://www.proteome-factory.com>). At the Proteome Factory, *Pf*68 kDa was digested with trypsin and analyzed by tandem high-performance liquid chromatography (HPLC) and mass spectrophotometry (MS) utilizing electro spray ionization Fourier transform ion cyclotron resonance (ESI-FTICR). The experimental molecular masses of the peptides as determined by MS were then compared to theoretical molecular masses of peptides produced via an *in silico* digestion of proteins from the *P. falciparum* genome database using the MASCOT protein identification program (Matrix Science Ltd).

The Mab7 for purify *Pf*68 kDa used in the column was from ascitic fluids. This ascitic fluid was prepared before the doctoral Thesis and was previously approved by Comité Técnico de Investigaciones CT-152-94 from National Institute of Health, Bogotá-Colombia.

3. Results and discussion {#sec3}
=========================

The 68 kDa protein was affinity purified using Mab7. A total of 260 μg of a *P. falciparum* extract was passed over an affinity column, and following elution, 0.156 μg of protein was recovered. The eluted protein consisted of a single polypeptide of approximately 68 kDa that was recognized by Mab7 ([Figure 1](#fig1){ref-type="fig"}). Contaminating bands were quite minor in this purified preparation. The purified protein was then subjected to immunoblotting using Mab7 ([Figure 1](#fig1){ref-type="fig"}). Mab7 only recognized the 68 kDa protein. These results demonstrated that *Pf*68 kDa was successfully purified.Figure 1[Analysis of the affinity-purified]{.ul}*[Pf]{.ul}*[68 kDa]{.ul}. The purified *Pf*68 kDa was analyzed by SDS-PAGE and silver staining (left panel). The same samples were also analyzed by immunoblotting with Mab7 (right panel). Lanes 1 correspond to the crude extract before affinity chromatography, and lanes 2 correspond to the purified product after affinity chromatography. A single band corresponding to *Pf*68 kDa (denoted with arrow) is recognized by Mab7 after affinity chromatography. The complete images of SDS-PAGE silver-stained gel correspond to the right panel of [Figure 1](#fig1){ref-type="fig"}, and the immunoblotting membrane corresponds to the right panel of [Figure 1](#fig1){ref-type="fig"}; both figures included as supplementary material (SM-1 and SM-2).Figure 1

The band corresponding to the 68 kDa protein was excised from a gel and shipped to the Proteome Factory AG (<https://www.proteome-factory.com>). At the Proteome Factory, *Pf*68 kDa was digested with trypsin and the masses of the peptides were determined by mass spectrophotometry (MS). The experimental molecular masses of the peptides as determined by MS were then compared to theoretical molecular masses of peptides produced via an *in silico* digestion of proteins from the *P. falciparum* genome database.

The proteomic analysis of the purified 68 kDa protein was carried out twice. In both cases a single high-scoring match corresponding to *Pf*HSP70-2 (PF3D7_0917900) was identified. In one analysis the score for *Pf*HSP70-2 was 854 and the next highest scoring *P. falciparum* protein was 34. In the other analysis, the score for *Pf*HSP70-2 was 910 and the next highest scoring *P. falciparum* protein was 62. Many of the peptides exhibited highly significant matches with expect scores \<0.01 and 26 out of 27 peptides were considered as best matches ([Figure 2](#fig2){ref-type="fig"}). Furthermore, all of the peptides align with the *Pf*HSP70-2 sequence (Supplemental data). In addition, the fact that all of the peptides are associated with *Pf*HSP70-2 further indicated that the 68 kDa protein is highly purified and there are no co-migrating proteins in the sample. These results clearly demonstrate that the 68 kDa protein is equivalent to *Pf*HSP70-2.Figure 2[Peptide mapping of]{.ul}*[Pf]{.ul}*[68 kDa]{.ul}. Peptide masses following a trypsin digestion of *Pf*68 kDa were determined by mass spectrometry (Mr expt) and compared to theoretical peptide masses of proteins found in the *P. falciparum* genome (Mr calc). Twenty-six peptides from the 68 kDa protein exhibited top-ranked matches from *Pf*HSP70-2 peptides in the *P. falciparum* genome database (denoted in red). Only one peptide from the 68 kDa protein did not have a top-ranked match associated with *Pf*HSP70-2 (denoted in black). However, this peptide is found in the *Pf*HSP70-2 sequence (Supplemental Data) meaning all 27 peptides generated by the trypsin cleavage are from *Pf*HSP70-2. In addition, expect scores for many of the peptides were \<0.01 and therefore are highly significant. This analysis is a representative of two independent analyses which were equivalent.Figure 2

HSP70 is a family of highly conserved and ubiquitous molecular chaperones that function as protein folding catalysts ([@bib20]). Six paralogs of HSP70 have been identified in the *Plasmodium* genome ([@bib23]). Three of these paralogs are homologous to the organelle specific HSP70 proteins found in eukaryotes. Namely, *Pf*HSP70-1 corresponds to the cytosolic HSP70, *Pf*HSP70-2 corresponds to the ER HSP70, and *Pf*HSP70-3 corresponds to the mitochondrial HSP70. The ER-resident HSP70 is also known as glucose-regulated protein (Grp78) or as immunoglobulin-binding protein (BiP) ([@bib6]). Furthermore, *Pf*HSP70-2 has been previously localized to the ER in *P. falciparum* ([@bib13]). The *Pf*HSP70-2 gene is transcribed throughout the blood stage cycle of the parasite ([@bib16]). This is consistent with our previous observations that the PEC can be detected from the beginning of the ring stage throughout schizogony and fragments during the segmenter stage ([@bib3]). This indicates, that like the ER, the PEC fragments during segmentation and the budding merozoites contain the PEC.

Previously we published that there was an overlap between the compartments recognized by Mab7 and a polyclonal antibody against *Pf*HSP70-2 ([@bib3]). In particular, *Pf*HSP70-2 appears to be more extensively distributed in the parasite than the then described 68 kDa protein. This minor discrepancy may be due to differences between the epitopes recognized by the monoclonal and polyclonal antibodies. For example, the polyclonal anti-sera was raised against the last 11 amino acids of *Pf*HSP70-2 ([@bib13]) and the epitope of Mab7 is unknown. It could also be that the epitope recognized by Mab7 is more accessible in the PEC than in the entire ER. Or perhaps *Pf*HSP70-2 is more concentrated in the PEC than the remainder of the ER. In any event, this overlapping pattern of immunofluorescence is consistent with the PEC being a domain of the ER, or an ER-like organelle. In other words, *Pf*HSP70-2 is found in both the ER and PEC and the differences between the labeling with polyclonal antibodies and Mab7 could reflect differences in those two compartments whether they are two separate compartments or the PEC is a domain of the ER. Furthermore, a partial overlap between Mab7 and polyclonal antibodies against the COPII components *Pf*Sar1p and *Pf*Sec31p was previously described ([@bib3]).

The location of *Pf*HSP70-2 in the ER and PEC implies that it has a role in protein trafficking and secretion. Indeed, it is known that chaperones help to refold proteins moving between subcellular compartments or to maintain exported proteins in an unfolded state until they reach their final destination ([@bib10]). In regards to the malaria parasite, this function would be needed whether proteins are being transported to locations within the parasite, or to locations within the host erythrocyte. However, exporting and targeting proteins into the host erythrocyte entails more complexity ([@bib5]). From the PEC the exported proteins move into the parasitophorous vacuole and need to cross the parasitophorous vacuolar membrane (PVM). There is a protein complex in the vacuolar membrane called PTEX that translocates proteins into the erythrocyte cytoplasm ([@bib7]). After traversing the PVM, some of the exported proteins remain in the cytosol, but many proteins are trafficked through membranous structures established by the parasite, such as Maurers' clefts, to their final destinations in the host erythrocyte. Throughout this pathway proteins need to be maintained in an unfolded state and then ultimately exported proteins need to be correctly folded. Thus, chaperones are obviously important in the export of proteins into the host erythrocyte ([@bib12]).

An interactome of *Pf*HSP70-2 was analyzed in order to gain some further insight into the biology of *Pf*HSP70-2. Previously, several proteins interacting with *Pf*HSP70-2 were identified in a yeast two-hybrid screen ([@bib14]), and we carried out an evaluation of these proteins in regards to potential interactions with *Pf*HSP70-2. *Pf*HSP70-2 interacts with 16 proteins including itself ([Table 1](#tbl1){ref-type="table"}). Interaction of *Pf*HSP70-2 with itself is not unexpected since HSP70 is known to exist in various oligomer states ([@bib25]). Of particular relevance to this study, are two proteins involved in secretion and two exported proteins. Other interacting proteins included several chaperones as well as six proteins with various functions and three conserved *Plasmodium* proteins of unknown function. In that the yeast two-hybrid system can be prone to promiscuous interactions, some of the interactions may need to be further evaluated experimentally. Nonetheless, some of these interactions are consistent with the presumed functions of *Pf*HSP70-2.Table 1Interactome: *Plasmodium falciparum* proteins interacting with *Pf*HSP70-2 as detected by yeast two-hybrid system.Table 1Protein or Gene IDDomain(s)^a^Interactions^b^FunctionSecretory pathway and exported proteinsSEC1631vesicle coat protein required for ER transport vesicle buddingPIP5K34regulator of motility, secretion and signaling, activated by ARF1*Pf*EMP-12 + 38exported protein, ligand mediating cytoadherence of infected erythrocytes to endothelial cellsM1AAP24neutral aminopeptidase, trafficked through parasitophorous vacuoleChaperones and protein-protein interactionsP*f*HSP70-21 + 2+3 (B)^c^2 + 3 (P)17chaperone, ER*Pf*HSP70-1312chaperone, cytoplasmHEP114maintain structure and function of HSP70-3 (mitochondrial)KELCH1015Kelch-repeat β-propellers are generally involved in protein--protein interactions*Plasmodium* proteins of presumed functionsHUEL136protein degradation via proteosomeRAD23122DNA repairHMGB31 + 27DNA binding, chromatin structure, transcriptionCCT17Lipid synthesisGLYRS32glycine-tRNA ligase, protein synthesisCEN236cytoskeleton protein with key roles in cell division, including centrosome duplicationConserved *Plasmodium* proteins of unknown functionPF3D7_06060002 + 37PF3D7_0817300117PF3D7_146450015[^1]

For example, the interaction of *Pf*HSP70-2 with proteins involved in secretion and exported proteins is consistent with *Pf*HSP70-2 localization to the ER and PEC. For example, Sec16 plays a role in the assembly of COPII coats at ER exit sites ([@bib24]). The overlap between COPII components, Sec31 and Sar1, and *Pf*HSP70-2 have been previously demonstrated ([@bib3]). Phosphatidylinositol-4-phosphate 5-kinase (PIP5K) is also involved in the regulation of secretion and is activated by ARF1. ARF1 is the target of Brefeldin A and Brefeldin A was originally used to identify the PEC ([@bib29]). Although further work is needed to conclusively demonstrate an interaction between *Pf*HSP70-2 between Sec16 and PIP5K, these results are consistent a role for *Pf*HSP70-2 in protein trafficking.

Interactions between chaperones and cargo proteins are well known ([@bib10]). And in this regard, *Pf*HSP70-2 also interacts with two proteins that are exported from the parasite: *Pf*EMP1 and an aminopeptidase of the M1 family (M1AAP). *Pf*EMP1 is expressed on the surface of infected erythrocytes and mediates cytoadherence to endothelial cells. Substantial work has been done on the trafficking of *Pf*EMP1 from the parasitophorous vacuole to the erythrocyte membrane ([@bib11]) but little is known about the initial steps of *Pf*EMP1 export. Presumably, this involves passage through either the ER or PEC before export into the parasitophorous vacuole. The M1AAP is also exported into the parasitophorous vacuole in route to its transport to the food vacuole -- a lysosomal-like organelle ([@bib1]).

Interactions with other chaperones is not surprising in that chaperones form many functional networks in *Plasmodium* ([@bib5]) In addition, molecular chaperones account for approximately two percent of the *Plasmodium* genome and approximately five percent of the *Plasmodium* exportome. Interestingly, *Pf*EMP1 interacts with another HSP70 protein, called *Pf*HSP70-x. *Pf*HSP70-x is unique to *Plasmodium* and is exported into the host erythrocyte cytoplasm where it presumable functions as a chaperone ([@bib12]) Furthermore, deletion of the *Pf*HSP70-x gene interferes with the trafficking of *Pf*EMP1 to the host erythrocyte membrane and reduces cytoadherence ([@bib4]).

This study implicates *Pf*HSP70-2 in the export of parasite proteins into the host erythrocyte. Clearly more information is needed on the precise role of *Pf*HSP70-2 in this process as well as the role of other chaperones and co-chaperones. Furthermore, the uniqueness of this process in *Plasmodium* may provide useful therapeutic targets.
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The following is the supplementary data related to this article:Supplemental_data_1**Supplemental data 1**. [Alignment of peptides with]{.ul}*[Pf]{.ul}*[HSP70-2 sequence]{.ul}. Shown is the *Pf*HSP70-2 sequence with the peptides that had zero (0) missed cleavages, sequences with the peptides scoring \>20 in the MASCOT analysis colored in fuchsia. Trypsin peptide cleavage sites are denoted with a period (.). The downward arrows with numbers indicate the amino acid number in the sequence.The blue underline is the peptide identified in [Figure 2](#fig2){ref-type="fig"} that was not a top scoring match.Supplemental_data_1SM_1**Supplementary material (SM-1)**. [Analysis of the affinity-purified]{.ul}*[Pf]{.ul}*[68 kDa full image]{.ul}. Shown is the silver stained SDS-PAGE (10%) of complete gel and the lanes 14 and 15 corresponds lanes 1 and 2 of [Figure 1](#fig1){ref-type="fig"}.SM_1SM_2**Supplementary material (SM-2).**[Western blotting anlalysis]{.ul}. The gel shown in the SM-1 was transferred to the membrane and analysis of eluted fractions from immunoaffinity column. Shown the Western blotting full membrane corresponds to [Figure 1](#fig1){ref-type="fig"}, the lanes 1 and 2 (right side of [Figure 1](#fig1){ref-type="fig"})SM_2
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[^1]: ^a^The domain of PfHSP70-2 that binds to the identified protein (1 = N-terminal ATPase domain; 2 = Substrate binding domain; 3 = C-terminal domain). ^b^Number of other proteins interacting with identified protein as detected by yeast two hybrid system including *Pf*HSP70-2. This is a potential measure of promiscuity. ^c^B = bait and P = prey for interaction of *Pf*HSP70-2 with itself. Abbreviations: PIP5K (phosphatidylinositol-4-phosphate 5-kinase), ARF1 (ADP-ribosylation factor-1), EMP-1 (erythrocyte membrane protein-1), HSP (heat shock protein), HEP1 (HSP70-escort protein 1), HUEL (HECT-domain E3 ubiquitin ligase), HMGB3 (high mobility group protein B3), CCT (CTP: Phosphocholine cytidylyltransferase), GLYRS (glycyl-tRNA synthetase), CEN (centrin).
